Workflow
中国重组Ⅲ型人源化胶原蛋白行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan·2025-02-05 13:01

Investment Rating - The report does not explicitly state an investment rating for the recombinant type III humanized collagen protein industry Core Insights - The market size for recombinant type III humanized collagen protein products in China is projected to grow significantly from 54.61 million RMB in 2019 to 230.82 million RMB by 2028, indicating a robust growth trajectory [5] - The cumulative number of approved recombinant collagen products in China has increased from 23 in 2019 to an estimated 1,417 by 2028, reflecting a strong regulatory environment and market acceptance [10][16] - The average price of recombinant type III humanized collagen protein products is expected to rise gradually from 45.66 RMB in 2019 to 53.96 RMB by 2028, suggesting stable pricing power in the market [7][42] Market Size Overview - The market size for recombinant type III humanized collagen protein products is projected to reach 230.82 million RMB by 2028, with an estimated growth from 47.01 million RMB in 2024 to 65.72 million RMB in 2025 [5] - The sales volume of recombinant type III humanized collagen protein products is expected to increase from 10.83 million units in 2019 to 427.79 million units by 2028, indicating a strong demand growth [6][37] - The average consumption frequency of recombinant collagen products is projected to decline from 1.81 in 2019 to 0.42 by 2028, reflecting changing consumer behavior [33][40] Cumulative Approval Data - The cumulative number of approved recombinant type III humanized collagen products is expected to grow from 6 in 2019 to 1,025.2 by 2028, highlighting the increasing regulatory approvals in the sector [15][39] - The share of recombinant type III humanized collagen products in the overall recombinant collagen approvals is projected to increase from 26.09% in 2019 to 72.35% by 2028, indicating a growing market segment [13][17] Retail Market Overview - The retail market revenue for recombinant collagen products is expected to grow from 19 million RMB in 2019 to 319.75 million RMB by 2028, reflecting a compound annual growth rate (CAGR) driven by increasing consumer adoption [20][30] - The average price of recombinant collagen products is projected to increase from 45.76 RMB in 2019 to 54.08 RMB by 2028, suggesting a stable pricing environment amidst growing demand [24][31]